Alert! The coronavirus pandemic is paving the way for the growth of superbugs!

2020 May 16 News /BioValleyBIOON / - Global heroic efforts of researchers and health care professionals will ultimately help us control coronavirus pandemic and reduce the rate of new infectionsPeople's attention is still focused correctly on the destruction wrought by the pandemic being caused by the devastating loss of life and the impact on businesses and livelihoodsHowever, we also need to study other general crisis is affecting our health care system, and to predict the impact of a pandemic COVID-19 will they produceOne of the biggest threats to the world's health-care system facesisantibiotic resistanceeffective antibioticoccurrence deficiencies and existing medicinesbacterial drug resistanceleadsantibiotic resistance crisisSource: https: //cn.bing.commore than 90% of people at some stage of life will be openantibiotics But prescribe antibiotics is a finite process We do not have a steady stream of antibiotics to replace those antibiotics are no longer effective, and almost no new antibiotics have been developed At the same time, bacteria to antibiotics has been produced using a conventional resistance, even to the last antibiotic use (there are serious side effects of the drug, used only when all other antibiotics have failed ) also developed resistance we have now reached a stage: hospitals around the world have suffered infections are resistant to all known antibiotics secondary infections COVID-19 pandemic led to a large number of people with compromised immune systems admitted to the hospital, but the hospital is known resistant bacteria breeding ground Because of this inflow, related bacteria these hospitals will now have a broader potential target groups evidence emerging indicates that a large number of patients were COVID-19 diagnosis of secondary infection during hospitalization The source of these infections and the specific nature has yet to be fully studied, but there is some evidence that multidrug-resistant bacteria is one of caused by these bacteria secondary infections these secondary infections seem to influence survival of patients, data from Wuhan showed that all COVID 19-patient deaths in half of secondary infection This is because many bacteria associated with hospital especially suitable for people with weakened immune systems to establish infection in vivo History shows that the pandemic virus affected mortality secondary bacterial infection to a large extent, in 1918 and 2009 influenza pandemic, a large number of people die of secondary
bacterial infection, rather than the virus itself Another factor antibiotic resistance crisis will have a significant impact is the widespread use of antibiotics in COVID 19-patients latest data show that more than 90% of patients were receiving COVID-19 antibacterial therapy Rapidly increasing use of antibiotics, especially in hospitals, bacteria will have a strong selective pressure, so that resistance This may lead to increased incidence in the months and years after the end of the pandemic in drug-resistant infections 2016 published a report shows that by 2050, there are 10 million people infected annually resistant infections Given this forecast does not take into account the devastating impact of COVID-19, almost certainly will have to modify the schedule However, researchers are making a concerted effort to better understand the use of antibiotics COVID-19 patients US Department of Defense has just launched a study to track the use of antibiotics in secondary infection and COVID-19 patients The results of such studies will help guide the doctor when and how to prescribe antibiotics to patients COVID-19 Source: https: //cn.bing.com drug According to the World Health Organization, 252 kinds of antibiotics ongoing pre-clinical development, that is, they are currently Animals body for testing Unfortunately, these drugs only 2-5 kinds can be listed in the next 10 years One of the biggest obstacles to these drugs to market is the high cost of each drug up to $ 1 billion (816 million pounds) This makes it difficult to recover the investment, and to the development of these drugs causes enormous financial burden, many companies closed down under pressure By addressing this financial burden, and the development of new antibiotics as global research priorities, as we have in the development of COVID-19 vaccine you can see, we can ensure that more antibiotics are being developed to enter the market want to respond to a pandemic COVID-19 can be used as a blueprint for global cooperation in dealing with the crisis of antibiotic resistance, as we know, this threat could undermine our health care system and medical a (Biovalley Bioon.com) References: Coronaviruspandemicispavingthewayforanincreaseinsuperbugs [1] [2] Lackofnewantibioticsthreatensglobaleffortstocontaindrug-resistantinfections [3]
Understandingofantibiotics

[4] [5] ANevadawomandiesofasuperbugresistanttoeveryavailableantibioticintheUS Antibiotic-resistantbacteriainhealthcare [6] Epidemiologicalandclinicalcharacteristicsof99casesof2019novelcoronaviruspneumoniainWuhan, China: adescriptivestudy [7 ] AntibiotictreatmentforCOVID-19complicationscouldfuelresistantbacteria [8] ClinicalcourseandoutcomesofcriticallyillpatientswithSARS-CoV-2pneumoniainWuhan, China: asingle-centered, retrospective, observationalstudy [9] ClinicalcourseandriskfactorsformortalityofadultinpatientswithCOVID-19inWuhan, China: aretrospectivecohortstudy